{"id":"NCT02107092","sponsor":"ZS Pharma, Inc.","briefTitle":"Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.","officialTitle":"Open-label Extension to Study ZS-004 [Phase 3 Multicenter, Multi-phase, Multi-dose, Prospective, Randomized, Double-blind, Placebo-controlled Maintenance Study of Safety Efficacy of ZS (Sodium Zirconium Cycolsilicate) in Hyperkalemia.]","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05-31","primaryCompletion":"2015-07-31","completion":"2015-08-31","firstPosted":"2014-04-08","resultsPosted":"2018-08-15","lastUpdate":"2018-08-15"},"enrollment":123,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Hyperkalemia"],"interventions":[{"type":"DRUG","name":"Sodium Zirconium Cyclosilicate","otherNames":["ZS"]}],"arms":[{"label":"Sodium Zirconium Cyclosilicate","type":"EXPERIMENTAL"}],"summary":"Subjects who completed the Double-blind Randomized Maintenance Phase (DBRMP) Study Day 29 visit in ZS-004 (NCT 02088073) and have an i-STAT potassium value that is 3.5 to 6.2 mmol/l inclusive or who discontinued during ZS-004 due to hypo- or hyperkalemia in the DBRMP and have a mean i-STAT potassium value from two consecutive measurements at 0 and 60 minutes on Acute Phase Day 1/Maintenance Phase Day 1 that is 3.5 to 6.2 mmol/l inclusive may have the option to participate in ZS-004E (NCT 021070920). Subjects who discontinued from study ZS-004 due to any other reasons (e.g. adverse events, poor compliance, investigator decision) will not be entered into study ZS-004E. All subjects who continue into the extension study must begin dosing within two (2) days after the last dose of investigational product in ZS-004.","primaryOutcome":{"measure":"Proportion of Subjects With Average Serum Potassium Values â‰¤ 5.1 mmol/L","timeFrame":"11 months","effectByArm":[{"arm":"Extended Dosing Phase: ZS (Sodium Zirconium Cyclosilicate) QD","deltaMin":0.875,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":49,"countries":["United States","Australia","South Africa"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":123},"commonTop":["Hypertension","Urinary tract infection","Oedema peripheral","Constipation","Anaemia"]}}